SVA
NASDAQ
$6.47
Sinovac Biotech Ltd (SVA)
Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacture and marketing of vaccines against human infectious diseases in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
Sector:
Healthcare
Industry:
Biotechnology
Target: $3.52 (-45.60%)
Market Cap
$465M
Dividend Yield
850.00%
Beta (5Y)
-0.30
Price Chart
Valuation
Market Cap$465M
Forward P/E357.14
PEG30.00
P/S1.83
P/B1.82
Profitability
Total Revenue (TTM)$386M
Gross Profit (TTM)$443M
EBITDA-$393M
Profit Margin-51.5%
Operating Margin42.3%
EPS-$2.77
Financial Health
Debt-to-Equity11.1%
Dividend Yield850.00%
Growth & Risk
Revenue 5Y CAGR-5.44%
Beta (5Y)-0.30